Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4512-4517

  Ruppé, Etienne ^a,b   Lixandru, Brandusa ^c   Cojocaru, Radu ^d   Büke, Çaǧri ^e   Paramythiotou, Elisabeth ^f   Angebault, Cécile ^a,b   Visseaux, Claire ^b   Djuikoue, Ingrid ^b   Erdem, Esra ^e   Burduniuc, Olga ^d   El Mniai, Assiya ^b   Marcel, Candice ^b   Perrier, Marion ^b   Kesteman, Thomas ^b   Clermont, Olivier ^g   Denamur, Erick ^g   Armand Lefèvre, Laurence ^a,b   Andremont, Antoine ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c CANTACUZINO INSTITUTE   (Romania)

^d National Scientific Center for Preventive Medicine   (Moldova)

^e EGE UNIVERSITY   (Turkey)

^f NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^g INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; VIRULENCE FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES CULTURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; URINALYSIS; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CROSS-SECTIONAL STUDIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; URINARY TRACT; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 84882357003     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00238-13     Document Type: Article

References (28)

1. Lidin-Janson G, Kaijser B, Lincoln K, Olling S, Wedel H. 1978. The homogeneity of the faecal coliform flora of normal school-girls, characterized by serological and biochemical properties. Med. Microbiol. Immunol. 164:247-253.
2. Marshall B, Tachibana C, Levy SB. 1983. Frequency of tetracycline resistance determinant classes among lactose-fermenting coliforms. Antimicrob. Agents Chemother. 24:835-840.
3. Murray BE, Rensimer ER, DuPont HL. 1982. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N. Engl. J. Med. 306:130-135.
4. Tosh PK, McDonald LC. 2012. Infection control in the multidrugresistant era: tending the human microbiome. Clin. Infect. Dis. 54:707-713.
5. Hooton T. 2012. Uncomplicated urinary tract infection. N. Engl. J. Med. 366:1028-1037.
6. Yamamoto S, Tsukamoto T, Terai A, Kurazono H, Takeda Y, Yoshida O. 1997. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J. Urol. 157:1127-1129.
7. Moreno E, Andreu A, Pigrau C, Kuskowski M, Johnson J, Prats G. 2008. Relationships between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J. Clin. Microbiol. 46:2529-2534.
8. Plos K, Connell H, Jodal U, Marklund BI, Marild S, Wettergren B, Svanborg C. 1995. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J. Infect. Dis. 171:625-631.
9. Bhalla A, Pultz NJ, Ray AJ, Hoyen CK, Eckstein EC, Donskey CJ. 2003. Antianaerobic antibiotic therapy promotes overgrowth of antibioticresistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect. Control Hosp. Epidemiol. 24:644-649.
10. Gupta A, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE. 2011. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 52:103-120.
11. Bush K, Fisher JF. 2011. Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from gram-negative bacteria. Annu. Rev. Microbiol. 65:455-478.
12. Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166.
13. Messer JW, Leslie JE, Houghtby GA, Peeler JT, Barnett JE. 1982. Bacillus stearothermophilus disc assay for detection of inhibitors in milk: collaborative study. J. Assoc. Off. Anal. Chem. 65:1208-1214.
14. Pletz MW, Rau M, Bulitta J, De Roux A, Burkhardt O, Kruse G, Kurowski M, Nord CE, Lode H. 2004. Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrob. Agents Chemother. 48:3765-3772.
15. Saladin M, Cao VT, Lambert T, Donay JL, Herrmann JL, Ould-Hocine Z, Verdet C, Delisle F, Philippon A, Arlet G. 2002. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett. 209:161-168.
16. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
17. Johnson JR, Clermont O, Menard M, Kuskowski MA, Picard B, Denamur E. 2006. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J. Infect. Dis. 194:1141-1150.
18. Lefort A, Panhard X, Clermont O, Woerther PL, Branger C, Mentre F, Fantin B, Wolff M, Denamur E. 2011. Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J. Clin. Microbiol. 49:777-783.
19. Ruimy R, Genauzeau E, Barnabe C, Beaulieu A, Tibayrenc M, Andremont A. 2001. Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water. Infect. Immun. 69:584-588.
20. Berg RD. 1981. Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole. Infect. Immun. 33:854-861.
21. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A. 2004. Epidemiology and clinical features of infections caused by extended-spectrum betalactamase-producing Escherichia coli in nonhospitalized patients. J. Clin. Microbiol. 42:1089-1094.
22. Calbo E, Romani V, Xercavins M, Gomez L, Vidal CG, Quintana S, Vila J, Garau J. 2006. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum betalactamases. J. Antimicrob. Chemother. 57:780-783.
23. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R. 2004. Risk factors for the development of extended-spectrum betalactamase-producing bacteria in nonhospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. 23:163-167.
24. Tarkkanen AM, Heinonen T, Jogi R, Mentula S, van der Rest ME, Donskey CJ, Kemppainen T, Gurbanov K, Nord CE. 2009. P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin. Antimicrob. Agents Chemother. 53:2455-2462.
25. Bourgeois-Nicolaos N, Massias L, Couson B, Butel MJ, Andremont A, Doucet-Populaire F. 2007. Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo. J. Infect. Dis. 195:1480-1488.
26. Fantin B, Duval X, Massias L, Alavoine L, Chau F, Retout S, Andremont A, Mentre F. 2009. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J. Infect. Dis. 200:390-398.
27. Dethlefsen L, Relman DA. 2011. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. U. S. A. 108(Suppl 1):4554-4561.
28. Lerner A, Romano J, Chmelnitsky I, Navon-Venezia S, Edgar R, Carmeli Y. 2013. Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae. Antimicrob. Agents Chemother. 57:1474-1479.